Coya Therapeutics, Inc. (COYA)
4.68
+0.07
(+1.52%)
USD |
NASDAQ |
Feb 23, 16:00
4.665
-0.02
(-0.32%)
Pre-Market: 19:59
Coya Therapeutics SG&A Expense (Quarterly) : 2.557M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.132B |
| AbbVie, Inc. | 3.895B |
| Atea Pharmaceuticals, Inc. | 7.22M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Agenus, Inc. | 10.86M |